Article Details
Retrieved on: 2024-05-24 17:17:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wuhan YZY Biopharma Co., Ltd. announce that, the data from an interim analysis of Phase II clinical study of M701, a bispecific antibody drug ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here